Invest Stockholm invites you to a webinar on how Stockholm-Uppsala has emerged as a global leader in infection control.
Invest Stockholm has mapped more than 110 companies, specializing in this field, in addition to successful research groups. At this webinar you will meet three of them – Gradientech, Svenska Vaccinfabriken Produktion and Molecular Attraction. Also key opinion leader Anders Blanck, CEO Swedish Association of the Pharmaceutical Industry, will share his expertise perspectives.
Many challenges face the world today, but few are quite as universal as the threat of infections. The success in the sector is to a great extent thanks to the strong profile in life sciences in the Stockholm-Uppsala region: four leading universities and a world-class research hospital enable close collaboration between laboratory scientists and physicians. Together they present a unique opportunity for clinical development.
Join us to learn more!